臓器機能アッセイ:医療機器パイプライン分析2019

◆英語タイトル:Organ Function Assays - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDATA9120294
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年11月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥265,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥530,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD7,500 ⇒換算¥795,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Organ Function Assays – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Organ Function Assays – Medical Devices Pipeline Assessment, 2019″ provides an overview of Organ Function Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Organ Function Assays under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Organ Function Assays under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Organ Function Assays Overview 6
3 Products under Development 7
3.1 Organ Function Assays – Pipeline Products by Stage of Development 7
3.2 Organ Function Assays – Pipeline Products by Territory 8
3.3 Organ Function Assays – Pipeline Products by Regulatory Path 9
3.4 Organ Function Assays – Pipeline Products by Estimated Approval Date 10
3.5 Organ Function Assays – Ongoing Clinical Trials 11
4 Organ Function Assays – Pipeline Products under Development by Companies 12
4.1 Organ Function Assays Companies – Pipeline Products by Stage of Development 12
4.2 Organ Function Assays – Pipeline Products by Stage of Development 13
5 Organ Function Assays Companies and Product Overview 14
5.1 Boditech Med Inc Company Overview 14
5.1.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.2 China Medical Technologies Inc (Inactive) Company Overview 15
5.2.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
5.3 Cornell University Company Overview 18
5.3.1 Cornell University Pipeline Products & Ongoing Clinical Trials Overview 18
5.4 Daxor Corp Company Overview 19
5.4.1 Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 19
5.5 DSX Therapeutics LLC Company Overview 20
5.5.1 DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.6 French National Institute of Health and Medical Research Company Overview 21
5.6.1 French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 21
5.7 HepQuant Llc Company Overview 22
5.7.1 HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview 22
5.8 Humedics GmbH Company Overview 28
5.8.1 Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 Merck Millipore Corp Company Overview 29
5.9.1 Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 29
5.10 Myriad Genetics Inc Company Overview 30
5.10.1 Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Proteome Sciences Plc Company Overview 31
5.11.1 Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 31
5.12 Radboud University Medical Centre Company Overview 32
5.12.1 Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview 32
5.13 Schnellgen, Inc Company Overview 33
5.13.1 Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
6 Organ Function Assays- Recent Developments 34
6.1 Oct 01, 2019: Fortress Diagnostics announces £8m investment in new headquarters 34
6.2 Sep 25, 2019: Myriad Genetics expands Board of Directors with two additional members 34
6.3 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 35
6.4 Aug 27, 2019: Chris Cournoyer joins CareDx Board of Directors 36
6.5 Aug 13, 2019: Myriad Genetics reports fiscal fourth-quarter and full-year 2019 financial results 36
6.6 Aug 01, 2019: CareDx reports second quarter 2019 results 38
6.7 Jul 29, 2019: Siemens Healthineers continues to drive growth forward 39
6.8 Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers 41
6.9 Jul 02, 2019: Grace Colon succeeds Amy Abernethy on the CareDx Board 41
6.10 May 08, 2019: CareDx reports first quarter 2019 results 42
6.11 May 07, 2019: Myriad Genetics reports fiscal third-quarter 2019 financial results 43
6.12 May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter 44
6.13 Apr 04, 2019: HepQuant’s Disease Severity Index (DSI) demonstrates hepatic functional improvement in high percentage of NASH patients treated with obeticholic acid: Results from INTERCEPT 747-117 45
6.14 Mar 06, 2019: CareDx reports fourth quarter and FY 2018 results 46
6.15 Mar 04, 2019: Daxor Announces Rise in Kit Sales and Files Form N-CSR For 2018 48
6.16 Feb 20, 2019: Keith Hoffman joins HepQuant as Clinical Lab Manager 48
6.17 Feb 14, 2019: First patient enrolled in a pivotal trial of the HepQuant SHUNT Liver Diagnostic Test 49
6.18 Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim 49
6.19 Feb 05, 2019: Myriad Genetics reports fiscal second-quarter 2019 financial results 50
6.20 Jan 23, 2019: Proteome Sciences: Year-end trading update 51
6.21 Jan 07, 2019: CareDx Reports Preliminary Fourth Quarter and Full Year 2018 Financial Results 52
6.22 Dec 31, 2018: Myriad Genetics announced its former CEO Peter Durkee Meldrum passed away 54
6.23 Dec 17, 2018: CareDx Director Dr. Amy Abernethy Resigns Board Seat to Become Principal Deputy Commissioner of the FDA 55
6.24 Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed 55
6.25 Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed 56
6.26 Nov 26, 2018: CareDx names Reginald Seeto, MB.BS, as president and chief business officer 57
6.27 Nov 26, 2018: CareDx strengthens executive leadership team with the appointment of Reginald Seeto, MB.BS, as President and Chief Business Officer 57
6.28 Nov 09, 2018: HepQuant receives IDE approval from U.S. FDA to initiate clinical trial of the SHUNT Liver Diagnostic Kit 58
6.29 Nov 09, 2018: Mayo Clinic elects Kent Thielen, M.D., CEO of its Florida operations; Mayo’s board of trustees also names two new members 58
6.30 Nov 08, 2018: CareDx reports third quarter results 61
6.31 Nov 06, 2018: Proteome Sciences: Trading update confirmation of preferred provider status 62
6.32 Nov 05, 2018: Siemens Healthineers with strong finish in fourth quarter, full year targets for fiscal 2018 achieved 63
7 Appendix 65
7.1 Methodology 65
7.2 About GlobalData 68
7.3 Contact Us 68
7.4 Disclaimer 68

List of Tables
Table 1: Organ Function Assays - Pipeline Products by Stage of Development 7
Table 2: Organ Function Assays - Pipeline Products by Territory 8
Table 3: Organ Function Assays - Pipeline Products by Regulatory Path 9
Table 4: Organ Function Assays - Pipeline Products by Estimated Approval Date 10
Table 5: Organ Function Assays - Ongoing Clinical Trials 11
Table 6: Organ Function Assays Companies - Pipeline Products by Stage of Development 12
Table 7: Organ Function Assays - Pipeline Products by Stage of Development 13
Table 8: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14
Table 11: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 15
Table 18: Cornell University Pipeline Products & Ongoing Clinical Trials Overview 18
Table 21: Daxor Corp Pipeline Products & Ongoing Clinical Trials Overview 19
Table 24: DSX Therapeutics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
Table 27: French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview 21
Table 30: HepQuant Llc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 44: Humedics GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
Table 47: Merck Millipore Corp Pipeline Products & Ongoing Clinical Trials Overview 29
Table 50: Myriad Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 53: Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 31
Table 56: Radboud University Medical Centre Pipeline Products & Ongoing Clinical Trials Overview 32
Table 59: Schnellgen, Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 62: Glossary 67

List of Figures
Figure 1: Organ Function Assays - Pipeline Products by Stage of Development 7
Figure 2: Organ Function Assays - Pipeline Products by Territory 8
Figure 3: Organ Function Assays - Pipeline Products by Regulatory Path 9
Figure 4: Organ Function Assays - Pipeline Products by Estimated Approval Date 10
Figure 5: Organ Function Assays - Ongoing Clinical Trials 11

【掲載企業】

Boditech Med Inc
China Medical Technologies Inc (Inactive)
Cornell University
Daxor Corp
DSX Therapeutics LLC
French National Institute of Health and Medical Research
HepQuant Llc
Humedics GmbH
Merck Millipore Corp
Myriad Genetics Inc
Proteome Sciences Plc
Radboud University Medical Centre
Schnellgen, Inc

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[臓器機能アッセイ:医療機器パイプライン分析2019]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆